Frank Martin, Ph. D.

Partner
Caladrius Ventures

---

Frank has been a key contributor to the T1D Fund since its inception in 2016. Prior to this, he served as Senior Director of Research at Breakthrough T1D, where he led portfolios focused on risk screening, beta cell survival, and regeneration.

He completed a prestigious Presidential Post-Doctoral Fellowship at the Novartis Institutes of Biomedical Research, specializing in early T-cell development and autoimmunity. Frank earned his PhD in Pharmacology from Columbia University under the mentorship of Dr. Alice Prince, where his research centered on epithelial contributions to innate immune signaling in response to respiratory infection.

Currently, Frank is spearheading the development of several innovative biotechnology investment funds